Nj State Employees Deferred Compensation Plan Astrazeneca PLC Transaction History
Nj State Employees Deferred Compensation Plan
- $824 Million
- Q3 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Astrazeneca PLC stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 19,118 shares of AZN stock, worth $1.34 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
19,118
Previous 19,118
-0.0%
Holding current value
$1.34 Million
Previous $1.49 Million
0.13%
% of portfolio
0.18%
Previous 0.19%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,340Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.41 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.94 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.61 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.58 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.34 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $217B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...